Document is current

Article History

Received: 30 November 2016

Revised: 20 April 2017

Accepted: 4 May 2017

First Online: 27 July 2017

Competing interests

: Dr McEntire is the Chief Executive Officer of the ASI, and Drs Hunt and Dobson are members of the ASI Board of Directors. The sponsor had no role in the analysis and interpretation of data. Dr McEntire participated in design and conduct of the study; collection of data; review of the manuscript; and the decision to submit the manuscript for publication. Drs Dobson, Hunt and Corwin have full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis. Dr Dobson wrote the first draft of the manuscript. Dr Rhein reports grants from PCORI and non-financial support from Masimo, outside the submitted work. Dr James is part owner of Acetaminophen Toxicity Diagnostics, LLC, which is funded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) STTR/2R42DK079387, and she receives salary support for research from the National Center for Advancing Translational Sciences (NCATS) awarded to the Translational Research Institute at the University of Arkansas for Medical Sciences (UL1RR029884). The remaining authors declare no conflict of interest.